Malignant progression and recurrence rates following endoscopic treatment of gastric hyperplastic polyps

Abstract

Background

Evidence supporting management algorithms for gastric hyperplastic polyps (GHPs) remains insufficient. To reassess the treatment criteria for these lesions, we analyzed the rate of neoplastic progression and recurrence after endoscopic resection.

Methods

This retrospective study from a high-volume center included all patients diagnosed with GHPs between 2003 and 2022. We cross-referenced patient records with the National Cancer Registry to identify cases of subsequent gastric cancer, irrespective of endoscopic management. We evaluated the prevalence of neoplastic components within resected GHPs and examined associated risk factors. Finally, we assessed the local recurrence rate at endoscopic follow-up in patients who underwent endoscopic resection.

Results

889 patients were included (mean age 63.5 years; 66.9% female), with a median polyp size of 4 mm (interquartile range [IQR] 3–8 mm). Over a median follow-up of 30.5 months (IQR 11.1–61.2), gastric cancer developed in three patients (0.3%), yielding a cumulative incidence of 1.37% (95%CI 0.43%–4.30%). Of the 515 resected GHPs, neoplasia was found in 6 (1.2%), all measuring ≥20 mm and predominantly (5/6) with pedunculated morphology. Patient age (odds ratio [OR] 1.15, 95%CI 1.01–1.36; P = 0.04) and polyp size (OR 1.19, 95%CI 1.11–1.30; P < 0.001) were associated with neoplasia. Among 167 patients (32.4%) with follow-up data, 42 (25.1%) developed local recurrence.

Conclusions

The risk of malignant progression in GHPs is low, while local recurrence after endoscopic resection remains notable. Endoscopic treatment should be prioritized for pedunculated polyps ≥20 mm, as these are more likely to harbor neoplasia.

Publikationsverlauf

Eingereicht: 06. Januar 2025

Angenommen nach Revision: 09. Juni 2025

Accepted Manuscript online:
09. Juni 2025

Artikel online veröffentlicht:
01. August 2025

• References

• 1 Carmack SW, Genta RM, Schuler CM. et al. The current spectrum of gastric polyps: a 1-year national study of over 120,000 patients. Am J Gastroenterol 2009; 104: 1524-1532
• 2 Huang H, Rong Y, Wang M. et al. Analysis of gastroscopy results among healthy people undergoing a medical checkup: a retrospective study. BMC Gastroenterol 2020; 20: 412
• 3 Kővári B, Kim BH, Lauwers GY. The pathology of gastric and duodenal polyps: current concepts. Histopathology 2021; 78: 106-124
• 4 Forté E, Petit B, Walter T. et al. Risk of neoplastic change in large gastric hyperplastic polyps and recurrence after endoscopic resection. Endoscopy 2020; 52: 444-453
• 5 Elhanafi S, Saadi M, Lou W. et al. Gastric polyps: association with Helicobacter pylori status and the pathology of the surrounding mucosa, a cross sectional study. World J Gastrointest Endosc 2015; 7: 995
• 6 Morais DJ, Yamanaka A, Zeitune JMR. et al. Gastric polyps: a retrospective analysis of 26,000 digestive endoscopies. Arq Gastroenterol 2007; 44: 14-17
• 7 Banks M, Graham D, Jansen M. et al. British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut 2019; 68: 1545-1575
• 8 Evans JA, Chandrasekhara V, Chathadi KV. et al. The role of endoscopy in the management of premalignant and malignant conditions of the stomach ASGE Standards of Practice Committee. Gastrointest Endosc 2015; 82: 1-8
• 9 Corral JE, Keihanian T, Diaz LI. et al. Management patterns of gastric polyps in the United States. Frontline Gastroenterol 2019; 10: 16-23
• 10 The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc 2003; 58: S3–43.
• 11 Schlemper RJ, Riddell RH, Kato Y. et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000; 47: 251-255
• 12 Dixon MF, Genta RM, Yardley JH. et al. Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol 1996; 20: 1161-1181
• 13 von Elm E, Altman DG, Egger M. et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008; 61: 344-349
• 14 Dinis-Ribeiro M, Libânio D, Uchima H. et al. Management of epithelial precancerous conditions and early neoplasia of the stomach (MAPS III): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG) and European Society of Pathology (ESP) Guideline update 2025. Endoscopy 2025; 57: 504-554
• 15 Han AR, Sung CO, Kim KM. et al. The clinicopathological features of gastric hyperplastic polyps with neoplastic transformations: a suggestion of indication for endoscopic polypectomy. Gut Liver 2009; 3: 271-275
• 16 Kang KH, Hwang SH, Kim D. et al. The effect of Helicobacter pylori infection on recurrence of gastric hyperplastic polyp after endoscopic removal. Korean J Gastroenterol 2018; 71: 213-218
• 17 Goddard AF, Badreldin R, Pritchard DM. et al. The management of gastric polyps. Gut 2010; 59: 1270-1276
• 18 João M, Areia M, Alves S. et al. Gastric hyperplastic polyps: a benign entity? Analysis of recurrence and neoplastic transformation in a cohort study. GE Port J Gastroenterol 2021; 28: 328-335
• 19 Nam SY, Lee SW, Jeon SW. et al. Helicobacter pylori eradication regressed gastric hyperplastic polyp: a randomized controlled trial. Dig Dis Sci 2020; 65: 3652-3659